28 research outputs found

    Knowledge of the patients in respect to potential complications.

    No full text
    <p>A, possible serious complications; B, serious complications. Dashed line mark the average frequency of remembered complications.</p

    Positive answers of the patients just before the coronary angiography.

    No full text
    <p>Provided and assessed information were composed of general (G1-G3), periprocedural (Peri1-Peri4) and procedural (Pro1-Pro4) facts (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0015164#pone-0015164-t001" target="_blank">table 1</a>).</p

    Baseline characteristics of in- and out-patients.

    No full text
    <p>Baseline characteristics of in- and out-patients.</p

    Original X-ray showing CS cannulation in LAO 30° view.

    No full text
    <p>1. <b>A.1-3.</b> Standard cannulation technique using preformed sheets and hydrophilic wire. <b>B.1-3.</b> Steerable EP catheter with exact cannulation. <b>C.1-2.</b> CS angiogram and coronary wire guided LV-lead positioning.</p

    Effect of the time until thrombolysis onset on outcome.

    No full text
    <p>(A) Time dependent ROSC, (B) time dependent successful hospital discharge.</p

    Time-outcome relation.

    No full text
    <p>Time of thrombolysis onset, CPR time after thrombolysis and total CPR duration in patients with and without successful CPR (A), in patients with hospital discharge vs. those who died (B), and in patients with hospital discharge versus those with secondary lethality after initially successful CPR.</p

    DE versus RHC correlations.

    No full text
    <p>DE mPAP (B) was better correlated with RHC than sPAP (A). Dotted lines mark virtual best correlation of 1 and solid lines mark the real correlation. r indicates the correlation coefficient, sPAP indicates systolic pulmonary artery pressure.</p

    Study flowchart in accordance to the STARD criteria.

    No full text
    <p>In phase 0 diagnostic criteria were evaluated in 164 patients undergoing DE and RHC. In phase 1 the calculated cut-off value for mPAP was validated in a cohort of patients with the suspicion of PH.</p
    corecore